José Pedro Planco Panadés Gil
AuthID: R-000-J1J
11
12
TITLE: Plasmodium falciparum Multidrug Resistance Proteins (pfMRPs)
AUTHORS: Gil, JP; Fancony, C;
PUBLISHED: 2021, SOURCE: FRONTIERS IN PHARMACOLOGY, VOLUME: 12
AUTHORS: Gil, JP; Fancony, C;
PUBLISHED: 2021, SOURCE: FRONTIERS IN PHARMACOLOGY, VOLUME: 12
13
TITLE: Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-Limited Settings: Conclusions From the Council for International Organizations of Medical Sciences–Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting
AUTHORS: Peñas LLedó, E; Terán, E; Sosa Macías, M; Galaviz Hernández, C; Gil, JP; Nair, S; Diwakar, S; Hernández, I; Lara Riegos, J; Ramírez Roa, R; Verde, I; Tarazona Santos, E; Molina Guarneros, J; Moya, G; Rägo, L; LLerena, A;
PUBLISHED: 2020, SOURCE: Clinical Therapeutics, VOLUME: 42, ISSUE: 8
AUTHORS: Peñas LLedó, E; Terán, E; Sosa Macías, M; Galaviz Hernández, C; Gil, JP; Nair, S; Diwakar, S; Hernández, I; Lara Riegos, J; Ramírez Roa, R; Verde, I; Tarazona Santos, E; Molina Guarneros, J; Moya, G; Rägo, L; LLerena, A;
PUBLISHED: 2020, SOURCE: Clinical Therapeutics, VOLUME: 42, ISSUE: 8
14
TITLE: Prevalence of CYP2C8*2 and *3 among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment Full Text
AUTHORS: Lidia Habtemikael; Mulugeta Russom; Iyassu Bahta; Selam Mihreteab; Araia Berhane; Andreas Martensson; Jose Pedro Gil;
PUBLISHED: 2020, SOURCE: PHARMACOGENOMICS & PERSONALIZED MEDICINE, VOLUME: 13
AUTHORS: Lidia Habtemikael; Mulugeta Russom; Iyassu Bahta; Selam Mihreteab; Araia Berhane; Andreas Martensson; Jose Pedro Gil;
PUBLISHED: 2020, SOURCE: PHARMACOGENOMICS & PERSONALIZED MEDICINE, VOLUME: 13
INDEXED IN: 
Scopus 
WOS
Scopus WOS15
TITLE: Expansion of a specific plasmodium falciparum pfmdr1 haplotype in southeast asia with increased substrate transport Full Text
AUTHORS: Calçada, C; Silva, M; Baptista, V; Thathy, V; Silva Pedrosa, R; Granja, D; Ferreira, PE; Gil, JP; Fidock, DA; Veiga, MI;
PUBLISHED: 2020, SOURCE: mBio, VOLUME: 11, ISSUE: 6
AUTHORS: Calçada, C; Silva, M; Baptista, V; Thathy, V; Silva Pedrosa, R; Granja, D; Ferreira, PE; Gil, JP; Fidock, DA; Veiga, MI;
PUBLISHED: 2020, SOURCE: mBio, VOLUME: 11, ISSUE: 6
16
TITLE: Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy
AUTHORS: Aminatou Kone; Sekou Sissoko; Bakary Fofana; Cheick O Sangare; Demba Dembele; Aboubecrine Sedhigh Haidara; Nouhoum Diallo; Aoua Coulibaly; Aliou Traore; Sekou Toure; Kadidia Haidara; Kassim Sanogo; Issaka Sagara; Khalid B Beshir; José P Gil; Ogobara K Doumbo; Abdoulaye A Djimde;
PUBLISHED: 2020, SOURCE: International Journal of Infectious Diseases, VOLUME: 95
AUTHORS: Aminatou Kone; Sekou Sissoko; Bakary Fofana; Cheick O Sangare; Demba Dembele; Aboubecrine Sedhigh Haidara; Nouhoum Diallo; Aoua Coulibaly; Aliou Traore; Sekou Toure; Kadidia Haidara; Kassim Sanogo; Issaka Sagara; Khalid B Beshir; José P Gil; Ogobara K Doumbo; Abdoulaye A Djimde;
PUBLISHED: 2020, SOURCE: International Journal of Infectious Diseases, VOLUME: 95
17
TITLE: <p>Prevalence of <em>CYP2C8*2</em> and <em>*3</em> among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment</p>
AUTHORS: Lidia Habtemikael; Mulugeta Russom; Iyassu Bahta; Selam Mihreteab; Araia Berhane; Andreas Mårtensson; Jose Pedro Gil;
PUBLISHED: 2020, SOURCE: Pharmacogenomics and Personalized Medicine, VOLUME: Volume 13
AUTHORS: Lidia Habtemikael; Mulugeta Russom; Iyassu Bahta; Selam Mihreteab; Araia Berhane; Andreas Mårtensson; Jose Pedro Gil;
PUBLISHED: 2020, SOURCE: Pharmacogenomics and Personalized Medicine, VOLUME: Volume 13
18
TITLE: Plasmodium falciparum Plasmepsin 2 Duplications, West Africa
AUTHORS: Inoue, J; Silva, M; Fofana, B; Sanogo, K; Martensson, A; Sagara, I; Bjorkman, A; Veiga, MI; Ferreira, PE; Djimde, A; Gil, JP;
PUBLISHED: 2018, SOURCE: EMERGING INFECTIOUS DISEASES, VOLUME: 24, ISSUE: 8
AUTHORS: Inoue, J; Silva, M; Fofana, B; Sanogo, K; Martensson, A; Sagara, I; Bjorkman, A; Veiga, MI; Ferreira, PE; Djimde, A; Gil, JP;
PUBLISHED: 2018, SOURCE: EMERGING INFECTIOUS DISEASES, VOLUME: 24, ISSUE: 8
19
TITLE: Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial
AUTHORS: Issaka Sagara; Abdoul Habib Beavogui; Issaka Zongo; Issiaka Soulama; Isabelle Borghini-Fuhrer; Bakary Fofana; Aliou Traore; Nouhoum Diallo; Hamadoun Diakite; Amadou H Togo; Sekou Koumare; Mohamed Keita; Daouda Camara; Anyirékun F Somé; Aboubacar S Coulibaly; Oumar B Traore; Souleymane Dama; Siaka Goita; Moussa Djimde; Amadou Bamadio; ...More
PUBLISHED: 2018, SOURCE: The Lancet, VOLUME: 391, ISSUE: 10128
AUTHORS: Issaka Sagara; Abdoul Habib Beavogui; Issaka Zongo; Issiaka Soulama; Isabelle Borghini-Fuhrer; Bakary Fofana; Aliou Traore; Nouhoum Diallo; Hamadoun Diakite; Amadou H Togo; Sekou Koumare; Mohamed Keita; Daouda Camara; Anyirékun F Somé; Aboubacar S Coulibaly; Oumar B Traore; Souleymane Dama; Siaka Goita; Moussa Djimde; Amadou Bamadio; ...More
PUBLISHED: 2018, SOURCE: The Lancet, VOLUME: 391, ISSUE: 10128
20
TITLE: pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies
AUTHORS: Pedro P Gil; Krishna, S;
PUBLISHED: 2017, SOURCE: Expert Review of Anti-infective Therapy, VOLUME: 15, ISSUE: 6
AUTHORS: Pedro P Gil; Krishna, S;
PUBLISHED: 2017, SOURCE: Expert Review of Anti-infective Therapy, VOLUME: 15, ISSUE: 6
